Integer (NYSE:ITGR – Get Free Report) released its quarterly earnings results on Thursday. The medical equipment provider reported $1.30 EPS for the quarter, topping the consensus estimate of $1.24 by $0.06, Briefing.com reports. Integer had a return on equity of 11.25% and a net margin of 6.01%. The firm had revenue of $436.20 million for the quarter, compared to analyst estimates of $437.00 million. During the same period in the previous year, the company posted $1.14 EPS. Integer’s revenue for the quarter was up 9.0% on a year-over-year basis. Integer updated its FY24 guidance to $5.07-5.49 EPS and its FY 2024 guidance to 5.070-5.490 EPS.
Integer Stock Performance
Integer stock traded up $1.22 during trading hours on Friday, reaching $116.90. 460,076 shares of the company were exchanged, compared to its average volume of 330,642. Integer has a 12 month low of $69.40 and a 12 month high of $130.15. The firm has a market cap of $3.92 billion, a price-to-earnings ratio of 40.42, a PEG ratio of 1.84 and a beta of 1.11. The company has a current ratio of 3.32, a quick ratio of 2.01 and a debt-to-equity ratio of 0.76. The stock has a 50-day moving average of $119.11 and a 200 day moving average of $113.04.
Insider Transactions at Integer
In related news, EVP John A. Harris sold 312 shares of Integer stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $113.00, for a total value of $35,256.00. Following the transaction, the executive vice president now owns 1,157 shares in the company, valued at approximately $130,741. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, Director James F. Hinrichs sold 9,603 shares of the business’s stock in a transaction on Friday, May 24th. The shares were sold at an average price of $122.44, for a total transaction of $1,175,791.32. Following the transaction, the director now owns 7,424 shares of the company’s stock, valued at $908,994.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP John A. Harris sold 312 shares of the stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $113.00, for a total transaction of $35,256.00. Following the completion of the sale, the executive vice president now directly owns 1,157 shares of the company’s stock, valued at $130,741. The disclosure for this sale can be found here. Over the last three months, insiders sold 17,936 shares of company stock worth $2,130,937. 2.00% of the stock is owned by insiders.
Analysts Set New Price Targets
Get Our Latest Stock Analysis on ITGR
About Integer
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Further Reading
- Five stocks we like better than Integer
- Consumer Discretionary Stocks Explained
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
- 3 Warren Buffett Stocks to Buy Now
- Skechers Stock Shows Strength Among Consumer Discretionary Sector
- Comparing and Trading High PE Ratio Stocks
- Tech Stocks Tumble, These Stocks Present Buying Opportunity
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.